ADVM-022 Intravitreal Gene Therapy for DME
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Adverum Biotechnologies, Inc.
- Study ID
- NCT04418427
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 6E11 vg/eye of ADVM-022 — BIOLOGICALADVM-022 (AAV.7m8-aflibercept) is a recombinant, replication-incompetent adeno-associated virus (AAV.7m8) gene therapy vector carrying a coding sequence for aflibercept
- 2E11 vg/eye of ADVM-022 — BIOLOGICALADVM-022 (AAV.7m8-aflibercept) is a recombinant, replication-incompetent adeno-associated virus (AAV.7m8) gene therapy vector carrying a coding sequence for aflibercept
- Aflibercept — BIOLOGICALCommercially available Active Comparator
Study Details
A Phase 2, Multi-Center, Randomized, Double-Masked\*, Active Controlled Study of ADVM-022 (AAV.7m8-aflibercept) in Subjects with Diabetic Macular Edema \[INFINITY\]
Key Dates
- Start date
- May 28, 2020
- Status verified
- Jun 2025
- Primary completion
- Nov 22, 2022
- Completion
- Jun 14, 2023
Study Design
- Enrollment
- 36 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 16E11 vg/eye ADVM-022 +/- aflibercept 2mg IVT
- Experimental: 22E11 vg/eye ADVM-022 +/- aflibercept 2mg IVT
- Active Comparator: 3Aflibercept 2mg IVT
Primary Outcome Measure
Time to Worsening of DME Disease Activity in the Study Eye. [ Time Frame: Day 1 through 96 weeks ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Adverum Clinical Site | Phoenix | Arizona | 85014 | - |
| Adverum Clinical Site | Bakersfield | California | 93309 | - |
| Adverum Clinical Site | Beverly Hills | California | 90211 | - |
| Adverum Clinical Site | Golden | Colorado | 80401 | - |
| Adverum Clinical Site | Deerfield Beach | Florida | 33064 | - |
| Adverum Clinical Site | Reno | Nevada | 89502 | - |
| Adverum Clinical Site | Philadelphia | Pennsylvania | 19107 | - |
| Adverum Clinical Site | West Columbia | South Carolina | 29169 | - |
| Adverum Clinical Site | Nashville | Tennessee | 37203 | - |
| Adverum Clinical Site | Abilene | Texas | 79606 | - |
| Adverum Clinical Site | Austin | Texas | 78705 | - |
| Adverum Clinical Site | Houston | Texas | 77030 | - |
| Adverum Clinical Site | The Woodlands | Texas | 77384 | - |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Village-Integrated Eye Worker Trial IIRecruiting · University of California, San Francisco · San Francisco, California
- Fenofibrate for Prevention of DR WorseningPHASE3 · Recruiting · Jaeb Center for Health Research · Glendale, California
- Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)PHASE1 · Recruiting · Ocugen · Deerfield Beach, Florida